(4) That the quinidine treatment of auricular fibrillation is contra-indicated during the acute stage of exophthalmic goitre, but that it may be instituted with benefit during the more chronic stages of the disease or after thyroidectomy.
(5) That in the successful cases, the prophylactic administration of quinidine should be continued indefinitely. If this is practised relapse does not necessarily occur over quite long periods.
(6) That the following system of procedure should be adopted: In the absence of the special contra-indications already discussed, quinidine should be administered in all cases of recent onset (one year or less). It should not be administered in cases of long-standing fibrillation (three years or more) who remain well compensated on digitalis. In cases of moderate duration (one to three years) and in doubtful cases, the therapeutic possibilities of the treatment and the risks incurred must be explained to the patient, who should be allowed to make his own decision.
(7) That the maximum dosage on the standard system described should be limited to 9 gr. six-hourly.
Finally, I believe that the therapeutic results, which are obtained by the careful administration of quinidine, justify the slight risks incurred in the treatment of selected cases.
Dr. T. F. COTTON. My remarks are based on the experience which I have had during the past two years in the treatment of patients with quinidine outside the wards of a public hospital and on the results of treatment in the wards at University College Hospital, in the clinic of Sir Thomas Lewis.
My impression is that quinidine therapy in private practice is very much in the hands of the consultant. This, I think, is desirable in the present state of our knowledge. The general practitioner can and does recognize auricular fibrillation without the aid of the galvanometer or the polygraph. He knows from the many articles appearing in the medical journals that quinidine given by the mouth in cachets will restore a normal rhythm in a percentage of these cases. He has read of the contra-indications and the danger signals, and hesitates to undertake treatment on his own responsibility. He fears sudden death, the onset of failure and embolism. He seeks the advice of a consultant and is glad to entrust to him the management of the case. I think this is the experience of many of us in dealing with auricular fibrillation.
The main object of establishing a normal rhythm is to recover the ventricular rate which was present before the onset of auricular fibrillation.
The ventricular rate is usually high when the auricles are fibrillating, and in consequence of this high rate an extra load is placed upon the myocardium already damaged by disease. This is one of the principal causes of heart failure of the congestive type. One can keep the ventricular rate within normal limits by giving digitalis. Quinidine obviates the necessity of continuous digitalis administration. It is no hardship, nor is it inconvenient for the patient with signs of failure, to take digitalis for the remainder of his life. Some patients of this class cannot tolerate digitalis in any form, and the ventricular rate remains high. One would like to give quinidine. I tried quinidine in one of these cases, but with the very high ventricular rate alarming signs of failure developed and I was obliged to discontinue its administration after two days.
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In patients with considerable enlargement of the heart, it is possible to induce a normal rhythm. I have given quinidine in these cases not so much with the object of reducing the heart rate, for I could do this with digitalis, but with the hope of relieving distressing palpitation so common in these patients. I have combined digitalis and quinidine in these cases, as I feared the onset of failure from the high ventricular rate if quinidine were given alone. In all cases in which I have been able to restore a normal rhythm it has been of short duration.
In patients with slight or moderate enlargement and mitral stenosis, with no signs of failure or infection, I have never seen the development of symptoms that were in any way alarming, except in one case. A normal rhythm returned in about half of them ; some reverted to fibrillation. In a few the normal rhythm was present when they were last seen.
The most suitable case for quinidine is the young person without enlargement of the heart and no valvular disease, who develops auricular fibrillation after an infection or from some other cause. He is fit in every way until the onset of auricular fibrillation. With the new rhythm established, physical exercise easily produces signs of distress. His exercise tolerance is poor; he is no longer able to continue with his occupation if it is in any way arduous, and games like tennis, which he enjoyed, he can no longer play. With the normal rhythm restored, he is able to resume his normal life.
Another type of case suitable for treatment is the patient with a history of paroxysmal fibrillation, and auricular fibrillation established, i.e., of a few months' duration; the chances of a return of the normal rhythm are better than 50 per cent. in this class.
In paroxysmal fibrillation the attacks are fewer and of shorter duration if quinidine is given in small doses over a period of months. I am not sure that this holds good in simple paroxysmal tachyeardia, though I have seen considerable benefit ip such cases.
I have not seen any good results from quinidine administration in patients with extrasystoles.
With a history of embolism I would not attempt to restore a normal rhythm. The risk is, I believe, too great, of dislodging a mural thrombus when the auricles have again begun to contract. Briefly, these are my views concerning quinidine therapy. The indiscriminate use of this drug in auricular fibrillation is not justifiable. It should be given a trial in those cases of auricular fibrillation of recent origin presenting few signs of structural disease, i.e., little or no enlargement, no valve disease or early mitral stenosis. The failures and successes will be about equal in this group. A large majority of those with a normal rhythm will again be fibrillating within two years. If, after six months of normal rhythm, the auricles again fibrillate, quinidine may be expected to restore the normal rhythm a second time, the heart reacting to the drug very much as when first given. If the auricles fibrillate within a period of six months, I do not think much is to be gained by again restoring the normal rhythm.
In the treatment of paroxysmal tachyeardia with the auricles contracting regularly or fibrillating, quinidine has an important place. In those cases with paroxysms of long duration and frequent occurrence, much may be expected from quinidine administration given in small doses and over a long period. Paroxysmal tachycardia is a serious disability where there are signs of structural disease present. The results from quinidine in these cases are quite good. I am not sure that it is not an advantage to continue with the quinidine after the normal rhythm has returned, with a view to preventing the recurrence of fibrillation. In paroxysmal fibrillation and simple paroxysmal tachyeardia, I give quinidine in small doses, 0'2 grm. three or four times daily for months. This may be good practice in all cases: I have certainly not seen any harmful results from quinidine given in this way.
I have had one case of sudden death after 2'0 grm. of quinidine had been given in the usual way. The patient was a woman aged 50 with moderate enlargement, no valve disease, and a ventricular rate of 140-150 after slight effort. There were no signs of venous engorgement and no breathlessness at rest. The nurse had left her reading a book and quite comfortable; when the nurse returned a quarter of an hour later, she found her dead, lying in the same position. There was no autopsy. Death may have been due to ventricular fibrillation. I have seen the same thing happen with digitalis. I do not know whether quinidine was responsible for death in this case.
Signs of embolism have not occurred in any of my cases. I have always given quinidine to private patients with auricular fibrillation in a nursing home. Few patients require longer than a week's stay. If at the end of a week the normal rhythm has not returned, I dismiss the case as a failure. I insist on absolute rest in bed with the avoidance of all unnecessary movements. These precautions are taken to prevent giddinessa symptom of which complaint is often made-and to ward off syncopal attacks which are particularly alarming to the patient, the nursing staff, and sometimes to the physician. The giddiness I attribute to the rapid heart actiona quinidine effect-and the syncopal attacks are probably vagal in origin.
A test dose of 02 grm. quinidine sulphate is given on the day of admission, and if there is no idiosyncrasy for the drug, on the following day I give four doses of 0 4 grm. at intervals of three hours. On the third day I add an extra cachet, and from this time onwards the patient has 2 grm. daily. It is, of course, not possible to observe the effect of quinidine on the auricular rate without a galvanometer and chest leads. This is really not a serious handicap. With a return of the rhythm to normal it is easy to recognize the change with a stethoscope. Occasionally, the heart is irregular after auricular fibrillation has ceased from extrasystoles. It is best in these cases to make certain of the type of irregularity by taking a polygraphic tracing.
Dr. IUiescu has kindly given me the figures to date of cases treated in the clinic of Sir Thomas Lewis at University College Hospital. Quinidine was given in forty-two cases of established auricular fibrillation. The patients reverted to their normal condition in twenty-five (or 59 per cent.) of these cases. Ten have remained normal; seven for more than a year. Fibrillation returned in 50 per cent. of the cases with a normal rhythm restored within two weeks. Apparently, in these cases the successes and failures seemed to be quite independent of age, venous congestion, infection, type of valve disease, or degree of enlargement. Those with a long history of fibrillation were restored to their normal state as quickly as others with fibrillation of short duration.
Dr. F. PARKES WEBER said he wished to draw attention to a possible danger in connexion with quinidine treatment for auricular fibrillation.
